Evidence map›Paper›PMID 32169011›Full record

ReviewJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2020

Advances in simultaneous PET/MR for imaging neuroreceptor function.

Christin Y Sander, Hanne D Hansen, Hsiao-Ying Wey

Abstract readReview
In one paragraph

Review in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. PET-MRI Applications and Future Prospects in Psychiatry.Journal of magnetic resonance imaging : JMRI · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Novel voxelwise residual analysis of [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christin Y SanderAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, MA, USA.
Hanne D HansenAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, MA, USA.ORCID 0000-0001-5564-7627
Hsiao-Ying WeyAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, MA, USA.ORCID 0000-0002-1425-8489

Funding

Project 4P41EB015896 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2012 to 2018
$9.8M
Dopamine-induced PET Occupancy Explored by PET/fMRIR01NS112295 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MANDEVILLE, JOSEPH B · 2019 to 2023
$2.2M
Combined MRI/PET Imager for Simultaneous Acquisition of PET/MRI DataS10RR022976 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI JENKINS, BRUCE · 2007 to 2007
$2.0M
Imaging Epigenetic Dysregulation in Patients with Low Back PainUH2AR076741 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI WEY, HSIAO-YING · 2019 to 2019
$1.2M
Neuroepigenetic mechanisms of chronic low back pain using histone deacetylases PET imagingR61DA048485 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WEY, HSIAO-YING · 2019 to 2020
$1.0M
Imaging dopamine receptor adaptations and signaling pathways with combined PET/fMRI-SupplementR00DA043629 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI SANDER, CHRISTIN Y. · 2019 to 2021
$759k
Assessing Dynamic Opioid-Dopamine Interactions Using Simultaneous PET/MRIR00DA037928 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WEY, HSIAO-YING · 2016 to 2018
$747k
PET CAMERA FOR BRAIN IMAGING: SCHIZOPHRENIA, BIPOLAR DISORDERS10RR019933 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SORENSEN, ALMA GREGORY · 2006 to 2006
$500k
CYCLOTRON &RADIOCHEMISTRY: SUBSTANCE ABUSE, COCAINE, OPIOIDS10RR017208 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2004 to 2004
$500k
Carbon-11 Radiopharmaceutical Production SystemS10RR026666 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWNELL, ANNA-LIISA · 2010 to 2010
$462k
Measure Mu-opioid Receptor Desensitization in vivoR21DA047133 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WEY, HSIAO-YING · 2018 to 2019
$410k
Assessing Dynamic Opioid-Dopamine Interactions Using Simultaneous PET/MRIK99DA037928 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI WEY, HSIAO-YING · 2014 to 2015
$374k
NCRR NIH HHS S10 RR017208NCRR NIH HHS S10 RR019933NCRR NIH HHS S10 RR022976NCRR NIH HHS S10 RR026666NIAMS NIH HHS UH2 AR076741NIBIB NIH HHS P41 EB015896NIDA NIH HHS K99 DA037928NIDA NIH HHS K99 DA043629NIDA NIH HHS R00 DA037928NIDA NIH HHS R00 DA043629NIDA NIH HHS R21 DA047133NIDA NIH HHS R61 DA048485NINDS NIH HHS R01 NS112295
6 · The paper itself

Abstract

Hybrid imaging using PET/MRI has emerged as a platform for elucidating novel neurobiology, molecular and functional changes in disease, and responses to physiological or pharmacological interventions. For the central nervous system, PET/MRI has provided insights into biochemical processes, linking selective molecular targets and distributed brain function. This review highlights several examples that leverage the strengths of simultaneous PET/MRI, which includes measuring the perturbation of multi-modal imaging signals on dynamic timescales during pharmacological challenges, physiological interventions or behavioral tasks. We discuss important considerations for the experimental design of dynamic PET/MRI studies and data analysis approaches for comparing and quantifying simultaneous PET/MRI data. The primary focus of this review is on functional PET/MRI studies of neurotransmitter and receptor systems, with an emphasis on the dopamine, opioid, serotonin and glutamate systems as molecular neuromodulators. In this context, we provide an overview of studies that employ interventions to alter the activity of neuroreceptors or the release of neurotransmitters. Overall, we emphasize how the synergistic use of simultaneous PET/MRI with appropriate study design and interventions has the potential to expand our knowledge about the molecular and functional dynamics of the living human brain. Finally, we give an outlook on the future opportunities for simultaneous PET/MRI.

Indexed as

BrainHumansMagnetic Resonance ImagingMultimodal ImagingNeuroimagingPositron-Emission TomographySensory Receptor CellsDopamineopioidpharmacologyserotoninsimultaneous PET/MRI

Identifiers

PMID32169011
PMCPMC7238372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.